Rama Phosphates Past Earnings Performance
Past criteria checks 0/6
Rama Phosphates's earnings have been declining at an average annual rate of -23.1%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 8.1% per year.
Key information
-23.1%
Earnings growth rate
-23.0%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 8.1% |
| Return on equity | -6.1% |
| Net Margin | -3.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Rama Phosphates makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,655 | -222 | 464 | 0 |
| 30 Jun 24 | 6,275 | -246 | 349 | 0 |
| 31 Mar 24 | 6,032 | -311 | 322 | 0 |
| 31 Dec 23 | 6,593 | -252 | 270 | 0 |
| 30 Sep 23 | 7,510 | 127 | 265 | 0 |
| 30 Jun 23 | 8,295 | 258 | 323 | 0 |
| 31 Mar 23 | 8,748 | 409 | 346 | 0 |
| 31 Dec 22 | 8,400 | 433 | 152 | 0 |
| 30 Sep 22 | 8,722 | 567 | 198 | 0 |
| 30 Jun 22 | 8,705 | 656 | 233 | 0 |
| 31 Mar 22 | 8,783 | 700 | 355 | 0 |
| 31 Dec 21 | 8,797 | 769 | 559 | 0 |
| 30 Sep 21 | 7,911 | 669 | 499 | 0 |
| 30 Jun 21 | 6,577 | 555 | 841 | 0 |
| 31 Mar 21 | 5,805 | 421 | 269 | 0 |
| 31 Dec 20 | 4,681 | 318 | 289 | 0 |
| 30 Sep 20 | 4,333 | 272 | 292 | 0 |
| 30 Jun 20 | 4,426 | 187 | 648 | 0 |
| 31 Mar 20 | 4,484 | 177 | 263 | 0 |
| 31 Dec 19 | 5,188 | 190 | 209 | 0 |
| 30 Sep 19 | 5,442 | 171 | 186 | 0 |
| 30 Jun 19 | 5,810 | 197 | 660 | 0 |
| 31 Mar 19 | 6,067 | 194 | 233 | 0 |
| 31 Dec 18 | 5,543 | 168 | 276 | 0 |
| 30 Sep 18 | 5,204 | 134 | 291 | 0 |
| 30 Jun 18 | 4,257 | 90 | 660 | 0 |
| 31 Mar 18 | 3,729 | 54 | 208 | 0 |
| 31 Dec 17 | 3,806 | 67 | 259 | 0 |
| 30 Sep 17 | 3,661 | 74 | 238 | 0 |
| 30 Jun 17 | 3,838 | 82 | 221 | 0 |
| 31 Mar 17 | 3,739 | 85 | 194 | 0 |
| 31 Dec 16 | 3,663 | 63 | 130 | 0 |
| 30 Sep 16 | 3,564 | 64 | 139 | 0 |
| 30 Jun 16 | 3,716 | 82 | 139 | 0 |
| 31 Mar 16 | 3,890 | 81 | 169 | 0 |
| 31 Dec 15 | 3,629 | 50 | 592 | 0 |
| 30 Sep 15 | 3,861 | -26 | 605 | 0 |
| 30 Jun 15 | 4,025 | -59 | 594 | 0 |
| 31 Mar 15 | 3,990 | -98 | 164 | 0 |
| 31 Dec 14 | 4,339 | 8 | 609 | 0 |
| 30 Sep 14 | 4,657 | 1 | 612 | 0 |
| 30 Jun 14 | 5,369 | -18 | 608 | 0 |
| 31 Mar 14 | 5,318 | -21 | 606 | 0 |
| 31 Dec 13 | 6,031 | -56 | 682 | 0 |
Quality Earnings: 524037 is currently unprofitable.
Growing Profit Margin: 524037 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 524037 is unprofitable, and losses have increased over the past 5 years at a rate of 23.1% per year.
Accelerating Growth: Unable to compare 524037's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 524037 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).
Return on Equity
High ROE: 524037 has a negative Return on Equity (-6.12%), as it is currently unprofitable.